A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B‐Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation

The data that support the findings of this study are available from the corresponding author upon reasonable request. Deidentified individual participant data that underlie the reported results can be requested. The study protocol is included as a Supporting Information available with the online version of this article. Data S1: ejh70064-sup-0001-Supinfo.docx. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Authors

Institutions

Publication Details

Journal
European Journal Of Haematology
Published
2025-12-09
DOI
https://doi.org/10.1111/ejh.70064
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B‐Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation

Eric Samorodnitsky, Jonathan E. Brammer, Julie W. Reeser, Robert A. Baiocchi et al.
European Journal Of Haematology
Lymphoma Diagnosis and Treatment
article

A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B‐Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation

Eric Samorodnitsky, Jonathan E. Brammer, Julie W. Reeser, Robert A. Baiocchi, Jennifer Ann Woyach, Yazeed Sawalha, Kami J. Maddocks, Kerry Anne Rogers, Seema Ali Bhat, David A. Bond, John Reneau, Aseel Alsouqi, Ying Huang, Sameek Roychowdhury, Amy Smith, Beth Christian, Michael R. Grever
article en

Abstract

The data that support the findings of this study are available from the corresponding author upon reasonable request. Deidentified individual participant data that underlie the reported results can be requested. The study protocol is included as a Supporting Information available with the online version of this article. Data S1: ejh70064-sup-0001-Supinfo.docx. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

European Journal Of HaematologyVol. 116(3)
The Ohio State University (US)
Verastem Oncology
Openalex Percentile: Top 45%
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B‐Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation — Eric Samorodnitsky, Jonathan E. Brammer, et al. · European Journal Of Haematology (2025) | TGRS Research Map | TGRS